MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/ibd/izz200

Медицинская библиотека · Inflammatory bowel diseases · 2020

Pedictors of Perianal Fistula Relapse in Crohn's Disease.

Malian Audrey, Rivière Pauline, Bouchard Dominique, Pigot François, Eléouet-Kaplan Marianne, Favreau-Weltzer Charlotte, Poullenot Florian, Laharie David

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Despite an optimal medico-surgical management of perineal Crohn's disease (PCD), fistula relapse still occurs in 30% of patients. Our aim was to determine predictors of fistula relapse in patients in remission after treatment of a PCD lesion.

METHODS

Consecutive patients treated for fistulizing PCD have been included in a retrospective study when they achieved fistula remission within 3 months after the surgery. Remission was defined as the absence of any draining fistula at clinical examination. Primary outcome was the occurrence of a fistula relapse, defined as a subsequent perianal draining fistula or an abscess confirmed clinically and/or by pelvic MRI.

RESULTS

One hundred and thirty-seven patients (57% female, median age: 35 years) corresponding to 157 abscess events, including 120 (76.4%) treated by anti-TNF after drainage, achieved fistula remission after surgery. During the follow-up period (median duration: 43 months [interquartile range 26 to 64]), 34 (22%) patients experienced a fistula relapse within a median time of 1.8 years. Survival without fistula was 96.7% at 1 year, 78.4% at 3 years, and 74.4% at 5 years. Fistula relapse rates were not different in patients receiving infliximab or adalimumab (P = 0.66). In patients treated by anti-TNF at inclusion, discontinuation of anti-TNF therapy (odds ratio 3.49, P = 0.04), colonic location (OR 6.25, P = 0.01), and stricturing phenotype (odds ratio 4.39, P = 0.01) were independently associated with fistula relapse in multivariate analysis.

CONCLUSION

In patients achieving fistula remission of PCD, relapse rates are low and are not different between infliximab and adalimumab. Discontinuation of anti-TNF therapy is associated with increased relapse rate.

Для цитирования: Malian Audrey, Rivière Pauline, Bouchard Dominique, Pigot François, Eléouet-Kaplan Marianne, Favreau-Weltzer Charlotte, Poullenot Florian, Laharie David. Pedictors of Perianal Fistula Relapse in Crohn's Disease.. Inflammatory bowel diseases. 2020. DOI: 10.1093/ibd/izz200.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.